Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Dr. Nomi Prins: Gold, Silver, Uranium and More...

July 17, 2025

Maiden Drill Program Commences at Oasis Uranium Project

July 28, 2025

Group Eleven Announces Upsize of Private Placement to...

February 19, 2025

Osisko Metals

July 19, 2025

Syntholene Energy Announces Completion of Reverse Takeover

December 11, 2025

EB Tucker: Gold Will Do Great, but This...

January 1, 2025

Editor’s Picks: Gold Price Breaks US$3,400, Silver Added...

August 30, 2025

Chris Berry: The West Must Invest in Refinement...

July 11, 2025

Mario Innecco: Gold, Silver Breakout — What Record...

January 15, 2026

Rick Rule: Gold Stock Sweet Spot, Uranium’s New...

January 24, 2025